Literature DB >> 33012332

Visualizing the Consistency of Clinical Characteristics that Distinguish Healthy Persons, Glaucoma Suspect Patients, and Manifest Glaucoma Patients.

Jack Phu1, Sieu K Khuu2, Ashish Agar3, Ireni Domadious2, Anika Ng2, Michael Kalloniatis4.   

Abstract

PURPOSE: To use factor analysis to visualize and assess the reproducibility and consistency of clinical quantitative parameters that can optimally distinguish among healthy, glaucoma suspect, and manifest glaucoma patients at a cross-sectional level and thus to describe the transition of quantitative change among the diagnostic categories.
DESIGN: Retrospective cross-sectional study. PARTICIPANTS: The medical records of healthy, glaucoma suspect, and manifest glaucoma patients (diagnosed by expert clinicians) seen at the Centre for Eye Health in 2015 (n = 148, n = 664, and n = 129, respectively) and 2018 (n = 242, n = 464, and n = 126, respectively) were reviewed. One eye was selected for the study.
METHODS: Quantitative clinical measures (intraocular pressure [IOP], central corneal thickness [CCT], visual field [VF], and OCT) were extracted and binary logistic (backward stepwise) regression was performed to identify factors that dictated separation between diagnostic pairs. These were used systematically as inputs for factor analysis to determine a final model that could potentially predict a clinical diagnosis. MAIN OUTCOME MEASURES: Intraocular pressure, CCT, VF (mean deviation and pattern standard deviation) indices, and OCT optic nerve head parameters and thickness values (retinal nerve fiber layer [RNFL] and ganglion cell-inner plexiform layer).
RESULTS: Few clinical parameters were identified commonly as significant across all diagnostic pairings for 2015 (3 of 23: IOP, pattern standard deviation, and 7-o'clock RNFL thickness) and 2018 (1 of 23: vertical cup-to-disc ratio). Few parameters overlapped when comparing 2015 and 2018 results, highlighting inconsistencies in the models between years. Factor analysis showed good separation between healthy persons and glaucoma patients. Using biplots to visualize the data in 2-dimensional clusters, glaucoma suspect patients demonstrated substantial overlap with healthy and glaucoma cohorts. The contributions of each parameter to diagnostic separation changed between groups and years.
CONCLUSIONS: Despite advances in quantitative ocular imaging and perimetry, the transition among healthy, glaucoma suspect, and manifest glaucoma patients remains confounded by a lack of consistent, reproducible combinations of quantitative clinical criteria. These results highlight the nebulousness (at patient-, instrument-, and clinician-related levels) of glaucoma diagnosis that remains contingent on individual clinical expertise and assessment.
Copyright © 2020 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 33012332     DOI: 10.1016/j.ogla.2020.04.009

Source DB:  PubMed          Journal:  Ophthalmol Glaucoma        ISSN: 2589-4196


  4 in total

1.  Glaucoma Suspects: The Impact of Risk Factor-Driven Review Periods on Clinical Load, Diagnoses, and Healthcare Costs.

Authors:  Jack Phu; Katherine Masselos; Michael Sullivan-Mee; Michael Kalloniatis
Journal:  Transl Vis Sci Technol       Date:  2022-01-03       Impact factor: 3.283

2.  Clinical Evaluations of Macular Structure-Function Concordance With and Without Drasdo Displacement.

Authors:  Janelle Tong; Jack Phu; David Alonso-Caneiro; Sieu K Khuu; Michael Kalloniatis
Journal:  Transl Vis Sci Technol       Date:  2022-04-01       Impact factor: 3.048

3.  Prediction of visual field defects from macular optical coherence tomography in glaucoma using cluster analysis.

Authors:  Janelle Tong; David Alonso-Caneiro; Michael Kalloniatis; Barbara Zangerl
Journal:  Ophthalmic Physiol Opt       Date:  2022-05-22       Impact factor: 3.992

4.  Gaze tracker parameters have little association with visual field metrics of intrasession frontloaded SITA-Faster 24-2 visual field results.

Authors:  Jack Phu; Michael Kalloniatis
Journal:  Ophthalmic Physiol Opt       Date:  2022-05-22       Impact factor: 3.992

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.